Massachusetts Financial Services’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,000,811
| Closed | -$113M | – | 938 |
|
|
2025
Q1 | $113M | Sell |
1,000,811
-2,255
| -0.2% | -$241K | 0.04% | 367 |
|
|
2024
Q4 | $106M | Sell |
1,003,066
-3,151
| -0.3% | -$338K | 0.03% | 374 |
|
|
2024
Q3 | $109M | Buy |
1,006,217
+4,388
| +0.4% | +$479K | 0.03% | 377 |
|
|
2024
Q2 | $109M | Sell |
1,001,829
-10,113
| -1% | -$1.19M | 0.03% | 365 |
|
|
2024
Q1 | $134M | Sell |
1,011,942
-6,887
| -0.7% | -$860K | 0.04% | 338 |
|
|
2023
Q4 | $124M | Sell |
1,018,829
-186,215
| -15% | -$20.8M | 0.04% | 341 |
|
|
2023
Q3 | $135M | Buy |
1,205,044
+1,545
| +0.1% | +$196K | 0.05% | 309 |
|
|
2023
Q2 | $175M | Buy |
1,203,499
+19,407
| +2% | +$2.64M | 0.06% | 268 |
|
|
2023
Q1 | $153M | Sell |
1,184,092
-1,151,365
| -49% | -$145M | 0.05% | 282 |
|
|
2022
Q4 | $298M | Sell |
2,335,457
-293,789
| -11% | -$34.1M | 0.1% | 184 |
|
|
2022
Q3 | $275M | Sell |
2,629,246
-574,631
| -18% | -$63.1M | 0.1% | 188 |
|
|
2022
Q2 | $337M | Sell |
3,203,877
-333,844
| -9% | -$39.6M | 0.12% | 178 |
|
|
2022
Q1 | $452M | Sell |
3,537,721
-470,761
| -12% | -$56.7M | 0.13% | 162 |
|
|
2021
Q4 | $494M | Sell |
4,008,482
-51,003
| -1% | -$6.68M | 0.14% | 159 |
|
|
2021
Q3 | $577M | Sell |
4,059,485
-87,877
| -2% | -$12.9M | 0.17% | 142 |
|
|
2021
Q2 | $648M | Sell |
4,147,362
-287,759
| -6% | -$46.6M | 0.19% | 129 |
|
|
2021
Q1 | $689M | Sell |
4,435,121
-5,866,884
| -57% | -$909M | 0.21% | 124 |
|
|
2020
Q4 | $1.54B | Sell |
10,302,005
-154,862
| -1% | -$21.9M | 0.49% | 50 |
|
|
2020
Q3 | $1.38B | Sell |
10,456,867
-164,281
| -2% | -$21.5M | 0.5% | 50 |
|
|
2020
Q2 | $1.23B | Sell |
10,621,148
-362,496
| -3% | -$41.8M | 0.49% | 55 |
|
|
2020
Q1 | $1.08B | Sell |
10,983,644
-71,527
| -0.6% | -$9.38M | 0.51% | 55 |
|
|
2019
Q4 | $1.61B | Sell |
11,055,171
-374,357
| -3% | -$51.7M | 0.6% | 49 |
|
|
2019
Q3 | $1.52B | Sell |
11,429,528
-772,856
| -6% | -$99.8M | 0.61% | 47 |
|
|
2019
Q2 | $1.39B | Sell |
12,202,384
-311,508
| -2% | -$36.5M | 0.57% | 50 |
|
|
2019
Q1 | $1.55B | Sell |
12,513,892
-1,484,092
| -11% | -$169M | 0.65% | 44 |
|
|
2018
Q4 | $1.41B | Sell |
13,997,984
-359,343
| -3% | -$40.4M | 0.68% | 45 |
|
|
2018
Q3 | $1.83B | Sell |
14,357,327
-604,634
| -4% | -$71.9M | 0.75% | 38 |
|
|
2018
Q2 | $1.62B | Sell |
14,961,961
-543,453
| -4% | -$59.1M | 0.69% | 44 |
|
|
2018
Q1 | $1.64B | Sell |
15,505,414
-1,446,286
| -9% | -$168M | 0.7% | 40 |
|
|
2017
Q4 | $1.99B | Sell |
16,951,700
-1,565,858
| -8% | -$177M | 0.83% | 33 |
|
|
2017
Q3 | $2.11B | Sell |
18,517,558
-963,814
| -5% | -$111M | 0.91% | 28 |
|
|
2017
Q2 | $2.43B | Buy |
19,481,372
+186,937
| +1% | +$22.2M | 1.08% | 19 |
|
|
2017
Q1 | $2.29B | Sell |
19,294,435
-537,817
| -3% | -$61M | 1.07% | 18 |
|
|
2016
Q4 | $1.99B | Buy |
19,832,252
+2,226,528
| +13% | +$239M | 0.97% | 20 |
|
|
2016
Q3 | $2.22B | Buy |
17,605,724
+32,527
| +0.2% | +$4.02M | 1.08% | 14 |
|
|
2016
Q2 | $2.05B | Buy |
17,573,197
+1,380,675
| +9% | +$156M | 1.03% | 17 |
|
|
2016
Q1 | $1.68B | Buy |
16,192,522
+1,541,366
| +11% | +$149M | 0.87% | 27 |
|
|
2015
Q4 | $1.46B | Buy |
14,651,156
+5,717,445
| +64% | +$559M | 0.78% | 32 |
|
|
2015
Q3 | $815M | Buy |
8,933,711
+4,706,900
| +111% | +$472M | 0.46% | 60 |
|
|
2015
Q2 | $448M | Buy |
+4,226,811
| New | +$468M | 0.23% | 105 |
|
Other funds holding ZBH
Massachusetts Financial Services's ZBH Position: Q2 2025 in Review
Massachusetts Financial Services sold out of Zimmer Biomet (ZBH) in Q2 2025, closing a stake of 1,000,811 shares — an estimated $113M sold.
Massachusetts Financial Services first reported a position in ZBH in Q2 2015 and held it in 40 quarters. The position peaked at $2.43B in Q2 2017. 934 funds tracked by Wall St. Rank hold ZBH as of Q2 2025.
- Massachusetts Financial Services reported no remaining Zimmer Biomet position as of Q2 2025 after selling out during the quarter.
- Massachusetts Financial Services sold 1,000,811 Zimmer Biomet shares in Q2 2025, an estimated $113M.
- Massachusetts Financial Services first reported a position in Zimmer Biomet in Q2 2015 and held it in 40 quarters.
- Massachusetts Financial Services's Zimmer Biomet position peaked at $2.43B in Q2 2017.
- 934 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2025.
Based on Massachusetts Financial Services's 13F filing for Q2 2025, filed 8 Aug 2025.